Watchtower BioSurveillance Targets AI-Driven Biological Defense

Founder E. Russell McAllister, a veteran of federal COVID-19 response efforts, argues that current defense systems fail to handle the ambiguous, contradictory data typical of biological outbreaks. Watchtower’s approach relies on a continuously adapting AI layer that aggregates heterogeneous data streams. While the system automates sensing, triage, and evidence collection, McAllister emphasizes that final, consequential decisions remain under human control.

This shift toward autonomous defense comes as frontier AI labs increasingly flag biological risks, including the potential for models to assist in weapon development. McAllister views this as a strategic moment for Canada to establish sovereign capability in a high-stakes field. By leveraging small, high-speed technical teams, he believes the company can outmaneuver the slow, institutional inertia that often plagues national security infrastructure. The goal is to secure a defensive advantage before the next global health event, arguing that the geographic location of such intellectual property will be determined by whoever builds the necessary infrastructure first.